Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析

◆英語タイトル:Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1459
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Noevir Holdings Co Ltd (4928) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Noevir Holdings Co Ltd (Noevir Holdings), through its subsidiaries manufactures and markets skincare, and pharmaceuticals products. The company offers various skin care products such as beauty serums, face and body moisturizers, creams and lotions, moisturizing sheet mask, moisturizing gels, complete cleansing line including cleansing cream, cleansing milk, cleansing water and cleansing mouse, eye creams and cosmetics such as eye makeup line, blush, foundation and lip makeup line. It also offers cough drops, functional drinks, over the counter (OTC) pharmaceuticals, cold remedies, eye drops and other nutritional supplements. Noevir Holdings markets these products under excel, Noevir, Nameraka Honpo, NOV, Min Min Da Ha and Nanten Nodo Ame. The company merchandises and sells products through various sales channels including drug stores, general retailers, specialty goods stores, general merchandise stores (GMS), supermarkets, and convenience stores at various affordable prices across domestic and international markets. It also offers contract manufacturing cosmetics and quasi-drugs. The company has manufacturing facilities in Kyoto and Iga. Noevir Holdings is headquartered in Tokyo, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Noevir Holdings Co Ltd – Key Facts
Noevir Holdings Co Ltd – Key Employees
Noevir Holdings Co Ltd – Major Products and Services
Noevir Holdings Co Ltd – History
Noevir Holdings Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Noevir Holdings Co Ltd – Business Description
Business Segment: Cosmetics
Overview
Performance
Key Stats
Business Segment: Other
Overview
Performance
Business Segment: Pharmaceuticals and Health Food
Overview
Performance
R&D Overview
Noevir Holdings Co Ltd – Corporate Strategy
Noevir Holdings Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Noevir Holdings Co Ltd – Strengths
Noevir Holdings Co Ltd – Weaknesses
Noevir Holdings Co Ltd – Opportunities
Noevir Holdings Co Ltd – Threats
Noevir Holdings Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Noevir Holdings Co Ltd, Key Facts
Noevir Holdings Co Ltd, Key Employees
Noevir Holdings Co Ltd, Major Products and Services
Noevir Holdings Co Ltd, History
Noevir Holdings Co Ltd, Other Locations
Noevir Holdings Co Ltd, Subsidiaries
Noevir Holdings Co Ltd, Key Competitors
Noevir Holdings Co Ltd, Ratios based on current share price
Noevir Holdings Co Ltd, Annual Ratios
Noevir Holdings Co Ltd, Annual Ratios (Cont...1)
Noevir Holdings Co Ltd, Annual Ratios (Cont...2)
Noevir Holdings Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Noevir Holdings Co Ltd, Performance Chart (2015 - 2019)
Noevir Holdings Co Ltd, Ratio Charts

★海外企業調査レポート[Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Arena Pharmaceuticals Inc (ARNA)-製薬・医療分野:企業M&A・提携分析
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. Its pipeline portfolio encompasses etrasimod for multiple inflammatory indications; ralinepag for the treatment of pulmonary arterial …
  • SNC-Lavalin Group Inc (SNC)-石油・ガス分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Renata Ltd (RENATA):企業の財務・戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Bangladesh Ltd, is a pharmaceutical and animal health product company. Its pharmaceutical product portfolio comprises amino acid supplement, anti viral preparation, anti allergic preparations, anti asthmatic preparation, anti bacterial preparations, among …
  • Cenovus Energy Inc.:企業の戦略・SWOT・財務情報
    Cenovus Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Cenovus Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nuverra Environmental Solutions Inc (NES):石油・ガス:M&Aディール及び事業提携情報
    Summary Nuverra Environmental Solutions Inc (Nuverra), formerly Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, collection, tre …
  • Insurance Corporation of Barbados Limited:企業の戦略・SWOT・財務情報
    Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Qatar Islamic Bank:企業の戦略・SWOT・財務分析
    Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report Summary Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • WestWind Energy Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary WestWind Energy Pty Ltd (West Wind) is a renewable energy company that offers development, construction, operation and management of wind farms and other energy projects. The company provides energy consultation, planning, and maintenance services. It also operates and maintains wind turbine …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • TomTom NV (TOM2):企業の戦略的SWOT分析
    TomTom NV (TOM2) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Exactech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • Nippon Chemi-Con Corporation (6997):企業の財務・戦略的SWOT分析
    Nippon Chemi-Con Corporation (6997) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆